The mutation status for BRAF and NRAS in the patient tumors had previously been established by the Department of Pathology at Sahlgrenska University Hospital, and the results obtained for the melanoma tissues with the SiMSen-Seq technique regarding these two specific genes were in accordance with the previously established mutation (Table 1). Here, BRAF is linked to melanoma.